Proteomedix Company
Identification of novel biomarkers for the early detection of cancer
Funding Status:
N/A
Headquarters:
Schlieren, Zurich
Founded Date:
2010
Investor Type:
N/A
Investment Stage:
N/A
Total Funding:
$21.3M
Technology:
ELISA
Employee Number:
1-10
Number Of Exists:
N/A
Estimated Revenue:
$1M to $10M
Industry:
BioTech